Form 424B5 MARINUS PHARMACEUTICALS,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- US stock index futures slip as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Marinus Pharmaceuticals (MRNS) PT Lowered to $22 at Jefferies
November 9, 2022 8:04 AM ESTJefferies analyst Andrew Tsai lowered the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $22.00 (from $29.00) while maintaining a Buy rating.
The analyst commented, "We think the ongoing launch of Ztalmy (oral ganaxolone; GNX) in CDD rare-epilepsy ($100M+ peak sales) is executing... More
